Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Recurrence 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lymphoma 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15Whole-Body Irradiation 14Tacrolimus 13Mycophenolic Acid 13Busulfan 12Antilymphocyte Serum 11Rituximab 9Etoposide 7Methotrexate 6Cyclosporine 6Melphalan 5thymoglobulin 4Flow Cytometry 4Carboplatin 4Therapeutics 3Radiotherapy 3Lenalidomide 3In Situ Hybridization, Fluorescence 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Everolimus 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3fludarabine 2Vorinostat 2Vincristine 2Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Extranodal NK-T-Cell × Commerce × Clear all
NCT00481871 2020-01-07

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Acrotech Biopharma Inc.

Phase 1/2 Completed
119 enrolled 13 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡